Camptothecins: new enthusiasm for an old drug.

作者信息

Rowe P M

出版信息

Lancet. 1996 Mar 30;347(9005):892. doi: 10.1016/s0140-6736(96)91363-x.

DOI:10.1016/s0140-6736(96)91363-x

PMID:8622402

Abstract

摘要

相似文献

Camptothecins: new enthusiasm for an old drug.

Lancet. 1996 Mar 30;347(9005):892. doi: 10.1016/s0140-6736(96)91363-x.

[Irinotecan in colorectal cancer].[伊立替康用于结直肠癌]

Tumori. 2001 Jan-Feb;87(1 Suppl 1):S49-50.

FDA approves irinotecan as first-line therapy for colorectal cancer.

Oncology (Williston Park). 2000 May;14(5):652, 654.

[Therapeutic approach for colorectal cancer with topoisomerase as a molecular target].[以拓扑异构酶为分子靶点的结直肠癌治疗方法]

Nihon Rinsho. 2003 Sep;61 Suppl 7:472-5.

Colorectal cancer chemotherapy: irinotecan.

Semin Oncol. 2000 Oct;27(5 Suppl 10):138-43.

Topoisomerase-I inhibitors in the management of colon cancer.

Ann N Y Acad Sci. 1996 Dec 13;803:256-63. doi: 10.1111/j.1749-6632.1996.tb26395.x.

CPT-11 (irinotecan) in the treatment of colorectal cancer: a new mechanism of action for additional activity.CPT-11（伊立替康）治疗结直肠癌：一种产生额外活性的新作用机制。

Tumori. 1997 Jan-Feb;83(1 Suppl):S85-6.

Schedule-dependent efficacy of camptothecins in models of human cancer.喜树碱类药物在人类癌症模型中的时间依赖性疗效。

Ann N Y Acad Sci. 1996 Dec 13;803:188-201. doi: 10.1111/j.1749-6632.1996.tb26388.x.

Preclinical and clinical trials of topoisomerase inhibitors.拓扑异构酶抑制剂的临床前和临床试验。

Ann N Y Acad Sci. 2000;922:92-9. doi: 10.1111/j.1749-6632.2000.tb07028.x.

Experimental chemotherapeutic agents for the treatment of colorectal carcinoma.

Hematol Oncol Clin North Am. 1997 Aug;11(4):721-58. doi: 10.1016/s0889-8588(05)70458-5.

引用本文的文献

The role of plant-derived drugs and herbal medicines in healthcare.植物源药物和草药在医疗保健中的作用。

Drugs. 1997 Dec;54(6):801-40. doi: 10.2165/00003495-199754060-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验